Abbott Manufacturing Singapore Media Kit

February 26, 2009
Singapore — Abbott (NYSE: ABT) opened its largest nutrition product manufacturing facility in Singapore to meet increasing regional demand for its pediatric nutrition products, including Similac®. The facility will serve up to 1 million Asian infants and children each year. This represents the company's growing commitment to the region, its single largest investment in Asia and its largest nutrition investment at US$300 million (S$450 million).

Additionally, Abbott announced an agreement to open a new nutrition science research and development center in Singapore, where its scientists will focus on clinical trials and development of nutrition products tailored to Asian dietary needs. This center of excellence complements Abbott's new pharmaceutical research and development facility, opened last month in Singapore. More »

Fact Sheets Abbott Manufacturing Singapore Products Made at Abbott Manufacturing Singapore Abbott's Commitment to Quality and Safety Abbott's Commitment to Nutrition Research and Development Corporate Overview Abbott Singapore Abbott in Asia Abbott China Abbott Hong Kong Abbott Indonesia Abbott Malaysia Abbott Taiwan Abbott Vietnam Abbott Philippines

Video Abbott Manufacturing Singapore Video B Roll Images Facility  Singapore - day time (972x647 pixels) Singapore - night time (972x647 pixels) Products Gain growing-up milk (1181x1683 pixels) Gain pre-school milk (1181x1694 pixels) PediaSure Complete (1181x1575 pixels) Similac follow-on formula (1181x1689 pixels)